Loading...

Vasantha Jotwani, MD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Address4150 Clement St
San Francisco CA 94121
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Northwestern UniversityBS2003Biomedical Engineering
    Northwestern UniversityM.D.2008Feinberg School of Medicine
    University of California San FranciscoInternship2009Internal Medicine
    University of California San FranciscoResidency2011Internal Medicine
    University of California San FranciscoChief Residency2012Internal Medicine
    University of California San FranciscoClinical Fellowship2014Division of Nephrology

    Collapse Research 
    Collapse Research Activities and Funding
    Biomarkers of Drug-induced Kidney Injury in HIV
    NIH/NIDDK K23DK109868Sep 15, 2016 - Jun 30, 2021
    Role: Principal Investigator
    Novel biomarkers of kidney injury in HIV-infected men
    NIH/NIDDK F32DK103451Jul 3, 2014 - Jul 2, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Jotwani V, Atta MG, Estrella MM. Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy. J Am Soc Nephrol. 2017 Aug 07. PMID: 28784698.
      View in: PubMed
    2. Ix JH, Jotwani V, Shlipak MG. In Reply to 'Urinary Excretion of a1-Microglobulin Does Not Predict Graft Loss in Stable Kidney Transplant Recipients'. Am J Kidney Dis. 2017 Jul; 70(1):151-152. PMID: 28501241.
      View in: PubMed
    3. Chen R, Scherzer R, Hsue PY, Jotwani V, Estrella MM, Horberg MA, Grunfeld C, Shlipak MG. Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients. J Am Heart Assoc. 2017 Apr 24; 6(4). PMID: 28438737.
      View in: PubMed
    4. Park M, Katz R, Shlipak MG, Weiner D, Tracy R, Jotwani V, Hughes-Austin J, Gabbai F, Hsu CY, Pfeffer M, Bansal N, Bostom A, Gutierrez O, Sarnak M, Levey A, Ix JH. Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial. Am J Transplant. 2017 Mar 29. PMID: 28371433.
      View in: PubMed
    5. Jotwani V, Scherzer R, Estrella MM, Jacobson LP, Witt MD, Palella F, Ho K, Bennett M, Parikh CR, Ix JH, Shlipak M. Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study. Antivir Ther. 2017 Jan 05. PMID: 28054933.
      View in: PubMed
    6. Ix JH, Katz R, Bansal N, Foster M, Weiner DE, Tracy R, Jotwani V, Hughes-Austin J, McKay D, Gabbai F, Hsu CY, Bostom A, Levey AS, Shlipak MG. Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial. Am J Kidney Dis. 2016 Dec 23. PMID: 28024930.
      View in: PubMed
    7. Baxi SM, Scherzer R, Jotwani V, Estrella MM, Abraham AG, Parikh CR, Bennett MR, Cohen MH, Nowicki MJ, Gustafson DR, Sharma A, Young MA, Shlipak MG. Changes in Urinary Biomarkers over 10 Years is Associated with Viral Suppression in a Prospective Cohort of Women Living with HIV. J Acquir Immune Defic Syndr. 2016 Oct 18. PMID: 27759575.
      View in: PubMed
    8. Jotwani V, Scherzer R, Estrella MM, Jacobson LP, Witt MD, Palella FJ, Macatangay B, Bennett M, Parikh CR, Ix JH, Shlipak MG, et al. HIV Infection, Tenofovir Disoproxil Fumarate, and Urine a1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study. Am J Kidney Dis. 2016 Jun 7. PMID: 27287300.
      View in: PubMed
    9. Jotwani V, Scherzer R, Estrella MM, Jacobson LP, Witt MD, Palella F, Macatangay B, Bennett M, Parikh CR, Ix JH, Shlipak M, et al. Cumulative tenofovir disoproxil fumarate exposure is associated with biomarkers of tubular injury and fibrosis in HIV-infected men. J Acquir Immune Defic Syndr. 2016 Apr 15. PMID: 27088295.
      View in: PubMed
    10. Scherzer R, Lin H, Abraham A, Thiessen-Philbrook H, Parikh CR, Bennett M, Cohen MH, Nowicki M, Gustafson DR, Sharma A, Young M, Tien P, Jotwani V, Shlipak MG. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women. Nephrol Dial Transplant. 2016 Sep; 31(9):1478-85. PMID: 26754833; PMCID: PMC5009288 [Available on 09/01/17].
    11. Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV. Am J Kidney Dis. 2015 Jun; 65(6):889-98. PMID: 25921719; PMCID: PMC4615696 [Available on 06/01/16].
    12. Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Ix JH, Sarnak MJ, Parikh CR, Shlipak MG. Association of urine a1-microglobulin with kidney function decline and mortality in HIV-infected women. Clin J Am Soc Nephrol. 2015 Jan 7; 10(1):63-73. PMID: 25370597; PMCID: PMC4284407 [Available on 01/07/16].
    13. Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Devarajan P, Anastos K, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Grunfeld C, Parikh CR, Shlipak MG. Does HIV infection promote early kidney injury in women? Antivir Ther. 2014; 19(1):79-87. PMID: 23970313; PMCID: PMC3933452.
    14. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis. 2012 May; 59(5):628-35. PMID: 22206742; PMCID: PMC3324595.
    15. Jotwani V, Scherzer R, Choi A, Szczech L, Polak JF, Kronmal RA, Grunfeld C, Shlipak M. Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM). Am J Nephrol. 2011; 33(5):453-60. PMID: 21508633; PMCID: PMC3100378.
    16. Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes. 2008 Mar; 57(3):714-23. PMID: 18083785.
      View in: PubMed
    Vasantha's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP